- G62.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM G62.2 became effective on October 1, 2022.
- This is the American ICD-10-CM version of G62.2 – other international versions of ICD-10 G62.2 may differ.
ICD-10-CM G62.2 is grouped within Diagnostic Related Group(s):
- 073 Cranial and peripheral nerve disorders with mcc
- 074 Cranial and peripheral nerve disorders without mcc
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to G62.2:
- toxic NEC > Neuritis (rheumatoid) M79.2
- Jamaica (ginger) > Neuropathy, neuropathic G62.9
- arsenic > in (due to) G62.0
- lead > in (due to) G62.0
- organophosphate compounds > in (due to) G62.0
- toxic agent NEC > in (due to) G62.0
- toxic NEC > Neuropathy, neuropathic G62.9
- Jamaica ginger (jake) > Paralysis, paralytic (complete) (incomplete) G83.9
- arsenical > Polyneuropathy (peripheral) G62.9
- arsenic > in (due to) G62.1
- lead > in (due to) G62.1
- organophosphate compounds > in (due to) G62.1
- toxic agent NEC > in (due to) G62.1
- triorthocresyl phosphate > in (due to) G62.1
- lead > Polyneuropathy (peripheral) G62.9